Vancomycin: Discovery, Structure, and Mode of Action

Comprehensive practice questions covering the history, microbiology, chemical binding, and clinical pharmacology of Vancomycin based on lecture notes.

What organism was first isolated in 1952 from a soil sample in Borneo as the source of Vancomycin?

Streptomyces orientalis, which is currently referred to as Amycolatopsis orientalis, is known for producing Vancomycin, an antibiotic effective against certain bacterial infections.

What was the temporary laboratory designation given to the compound that eventually became known as Vancomycin?

The compound was initially named Compound 05865 during its early research and development phases before being officially named Vancomycin.

Why did Vancomycin earn the nickname "Mississippi Mud" during its initial development?

Vancomycin was colloquially referred to as "Mississippi Mud" due to its impure composition and muddy appearance, which reflected the challenges faced in its early formulation.

What is the specific spectrum of activity for Vancomycin regarding bacterial types?

Vancomycin possesses a narrow spectrum of activity, effectively targeting gram-positive bacteria while being ineffectual against gram-negative bacteria due to the differences in cellular structure.

What are the three primary mechanistic actions, collectively known as the "triple threat," that characterize Vancomycin's antibacterial properties?

Vancomycin's mechanism of action includes: 1. Inhibition of cell wall synthesis, thereby preventing bacteria from maintaining their structural integrity; 2. Increasing the permeability of bacterial cell membranes, disrupting cellular homeostasis; 3. Inhibition of RNA synthesis, impacting protein synthesis essential for bacterial survival.

To which terminal residues of the $NAM$ pentapeptide does Vancomycin specifically bind?

Vancomycin binds to the two terminal $D\\text{-alanine}$ residues of the pentapeptide $D\\text{-Ala-D-Ala}$, interfering with peptidoglycan cross-linking in bacterial cell wall synthesis.

How many hydrogen bonds does a single molecule of Vancomycin form with the $D\\text{-Ala-D-Ala}$ dipeptide, facilitating its mechanism of action?

A single Vancomycin molecule forms a total of five hydrogen bonds with the $D\\text{-Ala-D-Ala}$ dipeptide, enhancing its binding affinity and efficacy in disrupting cell wall synthesis.

What chemical structure is located at position 1 of the Vancomycin heptapeptide backbone, contributing to its binding capabilities?

The residue at position 1 of the Vancomycin heptapeptide backbone is $N\\text{-methyl-D-leucine}$, which plays a crucial role in providing structural integrity and the ability to bind to target peptides effectively.

What type of dimer does Vancomycin typically form to enhance its binding affinity for peptidoglycan ligands?

Vancomycin generally forms a back-to-back dimer; this configuration arises from the establishment of four hydrogen bonds between the anti-parallel orientations of the polypeptide backbones, significantly strengthening its interaction with bacterial cell walls.

Why is Vancomycin generally ineffective against Gram-negative bacteria?

The outer membrane of Gram-negative bacteria contains lipopolysaccharides that create a significant barrier, preventing Vancomycin from penetrating the cell wall and effectively targeting its synthesis.

For which specific gastrointestinal infection is Vancomycin administered orally, and why is this method necessary?

Vancomycin is typically administered orally for infections caused by Clostridiodes difficile (C. difficile) because this method allows the antibiotic to directly reach the gastrointestinal tract, where it exerts its effects on the bacteria.

What common side effect associated with Vancomycin infusion is characterized by a sudden red rash on the neck, face, and upper torso?

This reaction, known as Vancomycin infusion reaction (previously referred to as Red man syndrome), occurs due to the release of histamine in response to rapid infusion of the drug.

What specific types of drug levels need to be monitored to ensure the efficacy and evaluate the toxicity of Vancomycin therapy?

Monitoring of trough levels is essential to ensure that Vancomycin maintains sufficient therapeutic concentrations in the bloodstream without reaching toxic levels, aiding in effective treatment while minimizing side effects.

What is the mechanism of selective toxicity for Vancomycin, distinguishing its effect on bacteria from human cells?

Vancomycin exhibits selective toxicity by specifically targeting the peptidoglycan cell wall unique to bacteria; it binds to $D\\text{-alanine}$ residues that are not present in human cells, allowing it to disrupt bacterial viability without harming human tissues.

Which enzymes facilitate the joining of pentapeptides from one $NAM$ monomer to another during the cell wall synthesis process, which Vancomycin targets?

Transpeptidase enzymes are responsible for cross-linking the pentapeptides of $NAM$ monomers during cell wall synthesis, a process that Vancomycin disrupts to inhibit bacterial growth.

What structural characteristic of Vancomycin provides hydrophobic shielding for its carboxylate binding pocket, aiding in its binding mechanism?

The unique folding of the $n\\text{-methyl-leucine}$ residue at position 1 affords hydrophobic shielding around the carboxylate binding pocket, enhancing Vancomycin's binding affinity to its peptide targets.

What term describes the phenomenon in which the binding of one antibiotic molecule increases the likelihood of a second molecule binding at the same site?

This phenomenon is known as co-operativity of binding, which can enhance the efficacy of antibiotics like Vancomycin by making it more likely for multiple molecules to engage their target simultaneously.